Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „safety“
Suchtreffer
Begriffe & Kennungen
Ahzantive · 4.8 · Summary of the safety profile
Eintrag öffnenAhzantive · 4.8 · Summary of the safety profile
Eintrag öffnenAhzantive · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAimovig · 4.8 · Summary of the safety profile
Eintrag öffnenAjovy · 4.8 · Summary of the safety profile
Eintrag öffnenAkantior · 4.8 · Summary of safety profile
Eintrag öffnenAkeega · 4.8 · Summary of the safety profile The overall safety profile of Akeega is based on pooled data from two clinical P
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · The safety profile of Akynzeo 235 mg/0.25 mg concentrate for solution for infusion was similar to that seen wi
Eintrag öffnenAkynzeo · 4.8 · The safety profile of Akynzeo 235 mg/0.25 mg powder for concentrate for solution for infusion was similar to t
Eintrag öffnenAldurazyme · 4.8 · Summary of the safety profile The majority of the related adverse events in the clinical trials were classifie
Eintrag öffnenAlecensa · 4.8 · Summary of the safety profile
Eintrag öffnenAlhemo · 4.8 · 78 of the clinical trial participants were adolescents (≥ 12 to < 18 years). The safety profile was similar be
Eintrag öffnenAlhemo · 4.8 · Summary of the safety profile
Eintrag öffnenAlhemo · 4.8 · The overall safety profile of concizumab is based on data from clinical trials. The most serious adverse react
Eintrag öffnenAlhemo · 4.8 · The safety and efficacy of concizumab in children aged below 12 years have not yet been established. No data a
Eintrag öffnenAlimta · 4.8 · Summary of the safety profile
Eintrag öffnen